Royal Sense Ltd. Launches 9 New Pharmaceutical Products, Including IETRACON, Isompra DSR, ILEVOFLOXA, Ugmntin LB, Pecolux Syrup, and JCZ-M Syrup

Royal Sense Ltd. has announced the launch of 9 new pharmaceutical products, available for sale from 3rd April, 2025. The new products include IETRACON 100Mg, IETRACON 200Mg, Isompra DSR, ILEVOFLOXA 500Mg, Ugmntin LB, Pecolux Syrup, and JCZ-M Syrup. These products cater to the domestic market and are used for various purposes, such as treating fungal infections, acid reflux, ulcers, gastroesophageal reflux disease (GERD), and bacterial infections. The company is excited about the launch and looks forward to the positive impact these products will have on the market.